Cargando…

The possibility of lapatinib treatment for breast cancer patients with central nervous system metastases. Case study and literature review

In patients with breast cancer with overexpression of the HER2 receptor, during treatment with trastuzumab, in 30% of cases brain metastases are observed. The use of lapatinib with capecitabine (L + C) seems to be an efficacious method of curing patients in whom the spread of cancer in this location...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolski, Janusz, Karczmarek-Borowska, Bożenna, Śmietana, Anetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687474/
https://www.ncbi.nlm.nih.gov/pubmed/23788948
http://dx.doi.org/10.5114/wo.2012.32494